ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0043

Assessing the Ability of Human Dental Pulp Stem Cells to Modulate the Macrophages Phenotype

Monia Maccaferri, Alessandra Pisciotta, Gianluca Carnevale, Carlo Salvarani and ELISA PIGNATTI, University of Modena and Reggio Emilia, Modena, Italy

Meeting: ACR Convergence 2023

Keywords: Inflammation, macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0040–0064) Innate Immunity Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Macrophages have been found to have a key role in Rheumatoid Arthritis. Depending on the microenvironment, macrophages exist in a dynamic functional state which could be mainly grouped in a pro-inflammatory state (M1 macrophages) and an anti-inflammatory state (M2 macrophages). In vitro, these conditions can approximately be reproduced by means of cytokines such as lipopolysaccharide (LPS) and IFNγ for M1 classically polarized macrophages or IL-4 and IL-13 for M2 alternatively polarized macrophages. Human dental pulp stem cells (hDPSCs) are adult stem cells which have been found to exert immunomodulatory functions both by cell-to-cell contact and in a paracrine way. The aim of our study was to assess the ability of hDPSCs to modulate the phenotype of human macrophages.

Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats by density-gradient centrifugation. PBMCs were differentiated to macrophages for 7 days in RPMI supplemented with M-CSF to obtain M0 macrophages. M0 macrophages were then polarized for 48 hours to M1 with LPS and IFNγ and to M2 macrophages with IL-4 and IL-13. hDPSCs were seeded at 1:1 ratio both directly on macrophages and into Transwell insert for indirect co-culture. Macrophages in direct co-culture with hDPSCs were separated with human anti CD14 micro beads. Protein expression was measured by Western Blot. Gene expression was assessed by RT-PCR.

Results: Surface markers expression analysis showed that M1 macrophages were CD80+, HK2+, HLA-DRB1+(p < 0.0001). Following co-culture, CD80 and HLA-DRB1 gene expression was further increased (p < 0.0001) (Fig. 1a), data were also confirmed by protein expression (Fig. 1b). M1 macrophages showed elevated expression of the transcriptional regulators JAK-1, -2, -3,STAT3, NF-kB and of pro-inflammatory cytokines (IL-6, TNFα, IL-1β, IFNγ) levels (p < 0.0001) (Fig. 2). They also express elevated levels of the immune modulators IDO, PD-L1 and ICAM-1 confirmed by protein expression (Fig. 3a, -b) and, of Fas-L and COX2 (Fig. 3a). The indirect co-culture enhanced the expression of STAT3, NF-kB, IL-1β, IL-6, Fas-L and decreased IFNγ expression (p < 0.0001) (Fig. 2, 3). The direct co-culture increased IL-6,ICAM-1 and COX2 expression and diminished IFNγ and Fas-L expression (p < 0.0001) (Fig. 2, 3). M2 macrophages were CD206+, DC-SIGN+ and ALOX15+ and only the direct co-culture was able to enhance the HLA-DR, CD206, DC-SIGN and IL-10 expression (p < 0.0001) (Fig. 1, 2). The direct co-culture increased the expression of CD206 and IL-10 in M0 non-polarized macrophages too (p < 0.0001) (Fig. 1, 2).

Conclusion: The biological factors secreted by hDPSCs supported the macrophages response to inflammation activating the STAT3 and NF-kB pathways and, in contrast, enhancing the inhibitory membrane molecule FasL expression. The cell-to-cell contact was shown to be the best immunomodulatory way reducing the IFNγ expression in inflammatory condition. Further, in presence of anti-inflammatory cytokines, hDPSCs directly promoted the polarization of M0 macrophages towards M2 phenotype and enhanced IL-10 expression which is a key cytokine in limiting the host immune response.

Supporting image 1

Fig. 1. Macrophages markers expression. a) Relative mRNA expression. M0 macrophages alone is the control group used to normalize data (considered 1) expressed as fold change. ****p<0.0001. b) Representative western blot depicting proteins immune-probed. β-actin levels were used as loading control. Indirect co-culture (IND CC), direct co-culture (DIR CC).

Supporting image 2

Fig. 2. Transcriptional regulators and cytokines expression calculated as fold change. ****p<0.0001. Indirect co-culture (IND CC), direct co-culture (DIR CC).

Supporting image 3

Fig. 3. Immune-modulator expression. a) Relative mRNA expression as fold change. b) Representative western blot lanes. ****p<0.0001. Indirect co-culture (IND CC), direct co-culture (DIR CC).


Disclosures: M. Maccaferri: None; A. Pisciotta: None; G. Carnevale: None; C. Salvarani: None; E. PIGNATTI: None.

To cite this abstract in AMA style:

Maccaferri M, Pisciotta A, Carnevale G, Salvarani C, PIGNATTI E. Assessing the Ability of Human Dental Pulp Stem Cells to Modulate the Macrophages Phenotype [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/assessing-the-ability-of-human-dental-pulp-stem-cells-to-modulate-the-macrophages-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-ability-of-human-dental-pulp-stem-cells-to-modulate-the-macrophages-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology